| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Plant Extracts | 9 | 2021 | 250 | 2.860 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 10 | 2021 | 28 | 2.420 |
Why?
|
| Lactic Acid | 9 | 2021 | 87 | 1.840 |
Why?
|
| Gene Expression Regulation, Neoplastic | 10 | 2021 | 781 | 1.800 |
Why?
|
| High-Throughput Screening Assays | 6 | 2021 | 63 | 1.700 |
Why?
|
| Glycolysis | 9 | 2021 | 66 | 1.560 |
Why?
|
| Biological Products | 3 | 2016 | 67 | 1.540 |
Why?
|
| Cell Survival | 24 | 2021 | 818 | 1.500 |
Why?
|
| Cell Line, Tumor | 24 | 2021 | 2128 | 1.320 |
Why?
|
| Glioma | 7 | 2016 | 76 | 1.300 |
Why?
|
| Hydroxamic Acids | 2 | 2018 | 30 | 1.260 |
Why?
|
| Histone Deacetylase Inhibitors | 2 | 2018 | 34 | 1.240 |
Why?
|
| Neuroblastoma | 11 | 2012 | 128 | 1.220 |
Why?
|
| L-Lactate Dehydrogenase | 3 | 2021 | 59 | 1.110 |
Why?
|
| Cytostatic Agents | 2 | 2021 | 6 | 1.040 |
Why?
|
| Monoamine Oxidase | 5 | 2012 | 31 | 0.960 |
Why?
|
| Mitochondria | 8 | 2012 | 454 | 0.960 |
Why?
|
| Plants, Medicinal | 4 | 2013 | 54 | 0.930 |
Why?
|
| Antineoplastic Agents, Phytogenic | 5 | 2021 | 107 | 0.930 |
Why?
|
| Anti-Inflammatory Agents | 5 | 2017 | 137 | 0.920 |
Why?
|
| Glucose | 7 | 2020 | 217 | 0.900 |
Why?
|
| Environment | 2 | 2014 | 130 | 0.840 |
Why?
|
| Dioscorea | 1 | 2021 | 2 | 0.840 |
Why?
|
| Thiophenes | 1 | 2021 | 31 | 0.830 |
Why?
|
| Gene Expression Profiling | 8 | 2021 | 600 | 0.820 |
Why?
|
| Pyridones | 1 | 2021 | 40 | 0.820 |
Why?
|
| Epigenesis, Genetic | 2 | 2014 | 198 | 0.790 |
Why?
|
| Herbicides | 2 | 2012 | 44 | 0.780 |
Why?
|
| Nitric Oxide Synthase | 5 | 2005 | 103 | 0.780 |
Why?
|
| Glucose-6-Phosphate Isomerase | 1 | 2020 | 5 | 0.780 |
Why?
|
| Breast Neoplasms | 5 | 2019 | 1426 | 0.750 |
Why?
|
| Hydrogen Peroxide | 7 | 2012 | 181 | 0.740 |
Why?
|
| Gene Expression | 2 | 2021 | 639 | 0.690 |
Why?
|
| Microglia | 3 | 2016 | 152 | 0.670 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2018 | 23 | 0.660 |
Why?
|
| Imidazoles | 2 | 2018 | 124 | 0.660 |
Why?
|
| Animals | 37 | 2019 | 14307 | 0.640 |
Why?
|
| Boswellia | 1 | 2017 | 2 | 0.640 |
Why?
|
| Naphthoquinones | 1 | 2018 | 35 | 0.640 |
Why?
|
| Triterpenes | 1 | 2017 | 12 | 0.630 |
Why?
|
| Cytokines | 3 | 2020 | 569 | 0.630 |
Why?
|
| Neurons | 4 | 2018 | 1130 | 0.620 |
Why?
|
| Melanoma | 1 | 2018 | 91 | 0.610 |
Why?
|
| Chemokine CXCL2 | 1 | 2016 | 9 | 0.600 |
Why?
|
| Nitrogen Dioxide | 1 | 2016 | 10 | 0.600 |
Why?
|
| Antioxidants | 6 | 2015 | 386 | 0.590 |
Why?
|
| Seeds | 1 | 2017 | 34 | 0.590 |
Why?
|
| Vitis | 1 | 2017 | 29 | 0.580 |
Why?
|
| Signal Transduction | 6 | 2018 | 1802 | 0.580 |
Why?
|
| Rats | 22 | 2019 | 3261 | 0.580 |
Why?
|
| Momordica | 2 | 2019 | 14 | 0.570 |
Why?
|
| Nerve Growth Factor | 2 | 2018 | 25 | 0.570 |
Why?
|
| Neoplasms | 2 | 2020 | 1033 | 0.560 |
Why?
|
| Dose-Response Relationship, Drug | 11 | 2017 | 984 | 0.550 |
Why?
|
| Sepsis | 1 | 2016 | 76 | 0.550 |
Why?
|
| Humans | 31 | 2023 | 34853 | 0.540 |
Why?
|
| Dopamine | 6 | 2004 | 232 | 0.530 |
Why?
|
| Neurogenesis | 1 | 2015 | 55 | 0.510 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2019 | 325 | 0.510 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2014 | 35 | 0.490 |
Why?
|
| Tumor Cells, Cultured | 10 | 2014 | 480 | 0.490 |
Why?
|
| Lipopolysaccharides | 8 | 2016 | 200 | 0.480 |
Why?
|
| Monoamine Oxidase Inhibitors | 2 | 2012 | 22 | 0.480 |
Why?
|
| Models, Biological | 3 | 2014 | 642 | 0.480 |
Why?
|
| Macrophages | 2 | 2016 | 431 | 0.480 |
Why?
|
| Escherichia coli | 1 | 2016 | 436 | 0.480 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 355 | 0.470 |
Why?
|
| Pyruvic Acid | 2 | 2003 | 16 | 0.460 |
Why?
|
| Cadmium Compounds | 1 | 2013 | 7 | 0.460 |
Why?
|
| Ecosystem | 1 | 2014 | 119 | 0.460 |
Why?
|
| Selenium Compounds | 1 | 2013 | 11 | 0.450 |
Why?
|
| Neuroglia | 2 | 2005 | 117 | 0.450 |
Why?
|
| Reactive Oxygen Species | 6 | 2018 | 416 | 0.450 |
Why?
|
| Nanocomposites | 1 | 2013 | 19 | 0.450 |
Why?
|
| Organic Chemicals | 1 | 2013 | 35 | 0.450 |
Why?
|
| Mitosis | 1 | 2013 | 97 | 0.440 |
Why?
|
| Oxidative Phosphorylation | 2 | 2010 | 49 | 0.430 |
Why?
|
| Mice | 13 | 2016 | 5668 | 0.420 |
Why?
|
| Genome | 1 | 2012 | 117 | 0.410 |
Why?
|
| MicroRNAs | 1 | 2017 | 386 | 0.410 |
Why?
|
| Astrocytes | 3 | 2015 | 203 | 0.410 |
Why?
|
| Parkinson Disease | 2 | 2011 | 167 | 0.400 |
Why?
|
| Homeostasis | 1 | 2012 | 172 | 0.380 |
Why?
|
| Chemokine CCL2 | 3 | 2017 | 82 | 0.380 |
Why?
|
| Acids | 1 | 2009 | 15 | 0.360 |
Why?
|
| Disulfides | 3 | 2015 | 77 | 0.360 |
Why?
|
| Cocaine | 6 | 2018 | 219 | 0.350 |
Why?
|
| Benzoquinones | 2 | 2021 | 34 | 0.340 |
Why?
|
| Apigenin | 2 | 2019 | 12 | 0.330 |
Why?
|
| Nanoparticles | 1 | 2013 | 294 | 0.330 |
Why?
|
| Adenosine Triphosphate | 4 | 2017 | 180 | 0.320 |
Why?
|
| Oxidopamine | 2 | 2005 | 18 | 0.310 |
Why?
|
| Oxidative Stress | 3 | 2013 | 874 | 0.310 |
Why?
|
| Nitric Oxide | 5 | 2018 | 287 | 0.310 |
Why?
|
| Histone Deacetylases | 2 | 2018 | 52 | 0.300 |
Why?
|
| Neoplasm Proteins | 2 | 2019 | 203 | 0.300 |
Why?
|
| PC12 Cells | 5 | 2019 | 84 | 0.290 |
Why?
|
| Nitric Oxide Synthase Type II | 7 | 2015 | 91 | 0.290 |
Why?
|
| Cytoprotection | 2 | 2003 | 32 | 0.290 |
Why?
|
| Oxygen Consumption | 4 | 2012 | 98 | 0.280 |
Why?
|
| Neuroprotective Agents | 2 | 2013 | 231 | 0.280 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2020 | 298 | 0.270 |
Why?
|
| Isoenzymes | 3 | 2021 | 149 | 0.270 |
Why?
|
| Antineoplastic Agents | 4 | 2021 | 756 | 0.270 |
Why?
|
| MAP Kinase Signaling System | 2 | 2018 | 162 | 0.270 |
Why?
|
| Cell Cycle | 3 | 2021 | 309 | 0.270 |
Why?
|
| Acetylcysteine | 3 | 2015 | 58 | 0.260 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2016 | 109 | 0.260 |
Why?
|
| Oxidation-Reduction | 6 | 2012 | 407 | 0.260 |
Why?
|
| Neurotoxins | 1 | 2005 | 52 | 0.250 |
Why?
|
| Smoke | 1 | 2005 | 39 | 0.250 |
Why?
|
| Allyl Compounds | 2 | 2015 | 47 | 0.250 |
Why?
|
| Ubiquinone | 1 | 2004 | 21 | 0.250 |
Why?
|
| Interferon-gamma | 4 | 2016 | 235 | 0.240 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2017 | 107 | 0.240 |
Why?
|
| Acetylcarnitine | 1 | 2003 | 8 | 0.240 |
Why?
|
| Chromatography, High Pressure Liquid | 5 | 2012 | 406 | 0.230 |
Why?
|
| Protective Agents | 1 | 2003 | 22 | 0.230 |
Why?
|
| Hydroxydopamines | 1 | 2003 | 4 | 0.230 |
Why?
|
| NAD | 1 | 2003 | 39 | 0.230 |
Why?
|
| Gluconeogenesis | 1 | 2003 | 10 | 0.230 |
Why?
|
| Brain Neoplasms | 3 | 2015 | 105 | 0.220 |
Why?
|
| Blotting, Western | 5 | 2012 | 834 | 0.220 |
Why?
|
| Chlorides | 2 | 2013 | 52 | 0.220 |
Why?
|
| Neurotransmitter Agents | 1 | 2002 | 57 | 0.220 |
Why?
|
| Gallic Acid | 2 | 2012 | 12 | 0.210 |
Why?
|
| Breast Feeding | 1 | 2023 | 105 | 0.210 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2012 | 100 | 0.210 |
Why?
|
| Phytotherapy | 1 | 2021 | 62 | 0.200 |
Why?
|
| Excitatory Amino Acids | 1 | 2001 | 7 | 0.200 |
Why?
|
| Isoquinolines | 1 | 2021 | 40 | 0.200 |
Why?
|
| Paclitaxel | 1 | 2021 | 48 | 0.200 |
Why?
|
| Glutathione | 4 | 2018 | 160 | 0.200 |
Why?
|
| Gene Regulatory Networks | 1 | 2021 | 115 | 0.200 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2001 | 92 | 0.200 |
Why?
|
| Tetrahydroisoquinolines | 2 | 2021 | 17 | 0.200 |
Why?
|
| Benzamides | 1 | 2021 | 76 | 0.200 |
Why?
|
| Gene Knockout Techniques | 1 | 2020 | 46 | 0.190 |
Why?
|
| Glutamic Acid | 1 | 2001 | 115 | 0.190 |
Why?
|
| Cyclotides | 1 | 2019 | 4 | 0.180 |
Why?
|
| Interleukin-1alpha | 2 | 2017 | 17 | 0.180 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2012 | 342 | 0.180 |
Why?
|
| Nerve Growth Factors | 1 | 2019 | 33 | 0.180 |
Why?
|
| Drug Interactions | 3 | 2012 | 137 | 0.170 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2018 | 209 | 0.170 |
Why?
|
| Colonic Neoplasms | 1 | 2021 | 181 | 0.170 |
Why?
|
| Nitrites | 4 | 2015 | 38 | 0.170 |
Why?
|
| Fish Oils | 1 | 1998 | 12 | 0.170 |
Why?
|
| Female | 12 | 2023 | 19873 | 0.160 |
Why?
|
| RNA, Messenger | 4 | 2015 | 1152 | 0.160 |
Why?
|
| Apoptosis | 4 | 2014 | 1317 | 0.160 |
Why?
|
| Neurites | 1 | 2018 | 35 | 0.160 |
Why?
|
| Smoking | 1 | 2005 | 903 | 0.160 |
Why?
|
| Food | 1 | 1998 | 95 | 0.150 |
Why?
|
| Aerobiosis | 2 | 2009 | 15 | 0.150 |
Why?
|
| Anaerobiosis | 2 | 2009 | 13 | 0.150 |
Why?
|
| I-kappa B Kinase | 1 | 2017 | 40 | 0.150 |
Why?
|
| DNA Repair | 1 | 2018 | 181 | 0.150 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2016 | 21 | 0.150 |
Why?
|
| Ibuprofen | 1 | 2016 | 33 | 0.140 |
Why?
|
| Molecular Conformation | 1 | 2017 | 150 | 0.140 |
Why?
|
| Gene Silencing | 1 | 2017 | 143 | 0.140 |
Why?
|
| Neutrophils | 1 | 2016 | 124 | 0.140 |
Why?
|
| DNA Damage | 1 | 2018 | 341 | 0.140 |
Why?
|
| Enzyme Activation | 1 | 2017 | 423 | 0.140 |
Why?
|
| Hela Cells | 1 | 2017 | 344 | 0.140 |
Why?
|
| Manganese Compounds | 2 | 2013 | 12 | 0.140 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 112 | 0.140 |
Why?
|
| Microtubules | 1 | 2016 | 113 | 0.140 |
Why?
|
| NF-kappa B p50 Subunit | 1 | 2015 | 13 | 0.140 |
Why?
|
| Silymarin | 1 | 2015 | 2 | 0.130 |
Why?
|
| Gene Expression Regulation | 3 | 2015 | 968 | 0.130 |
Why?
|
| Genes, p53 | 1 | 2015 | 24 | 0.130 |
Why?
|
| RNA, Small Interfering | 1 | 2017 | 391 | 0.130 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2015 | 53 | 0.130 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2015 | 90 | 0.130 |
Why?
|
| Histones | 2 | 2015 | 177 | 0.130 |
Why?
|
| Cells, Cultured | 2 | 2015 | 1442 | 0.120 |
Why?
|
| Sulfonamides | 1 | 2014 | 75 | 0.120 |
Why?
|
| Prostatic Neoplasms | 2 | 2012 | 794 | 0.120 |
Why?
|
| Models, Molecular | 1 | 2017 | 751 | 0.120 |
Why?
|
| Pyrimidines | 1 | 2014 | 112 | 0.110 |
Why?
|
| Manganese Poisoning | 1 | 2013 | 11 | 0.110 |
Why?
|
| DNA Breaks, Single-Stranded | 1 | 2013 | 12 | 0.110 |
Why?
|
| Sulfhydryl Compounds | 1 | 2013 | 46 | 0.110 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 1998 | 155 | 0.110 |
Why?
|
| DNA Fingerprinting | 1 | 2012 | 18 | 0.110 |
Why?
|
| Particle Size | 1 | 2013 | 200 | 0.110 |
Why?
|
| Heterochromatin | 1 | 2012 | 12 | 0.110 |
Why?
|
| Nucleosomes | 1 | 2012 | 27 | 0.110 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2012 | 79 | 0.110 |
Why?
|
| Time Factors | 3 | 2012 | 1681 | 0.110 |
Why?
|
| Ligands | 1 | 2013 | 317 | 0.100 |
Why?
|
| Liliaceae | 1 | 2010 | 2 | 0.100 |
Why?
|
| Boraginaceae | 1 | 2010 | 2 | 0.100 |
Why?
|
| Apiaceae | 1 | 2010 | 3 | 0.100 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 173 | 0.100 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2010 | 20 | 0.100 |
Why?
|
| Melanins | 1 | 2011 | 32 | 0.100 |
Why?
|
| Nucleus Accumbens | 4 | 2000 | 80 | 0.100 |
Why?
|
| Kinetics | 2 | 2003 | 650 | 0.100 |
Why?
|
| Prostate | 1 | 2011 | 136 | 0.090 |
Why?
|
| Vitamins | 1 | 2011 | 91 | 0.090 |
Why?
|
| Cell Hypoxia | 1 | 2010 | 55 | 0.090 |
Why?
|
| Corpus Striatum | 4 | 2000 | 99 | 0.090 |
Why?
|
| Alcohols | 1 | 2009 | 12 | 0.090 |
Why?
|
| Fermentation | 1 | 2009 | 25 | 0.090 |
Why?
|
| Ketones | 1 | 2009 | 17 | 0.090 |
Why?
|
| Aldehydes | 1 | 2009 | 65 | 0.090 |
Why?
|
| Amino Acids | 1 | 2009 | 139 | 0.080 |
Why?
|
| Piroxicam | 1 | 2008 | 2 | 0.080 |
Why?
|
| DNA Methylation | 1 | 2012 | 301 | 0.080 |
Why?
|
| MPTP Poisoning | 1 | 2008 | 10 | 0.080 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2008 | 28 | 0.080 |
Why?
|
| Cell Line | 3 | 2015 | 1289 | 0.080 |
Why?
|
| Cell Proliferation | 3 | 2021 | 1149 | 0.080 |
Why?
|
| Oxidants | 2 | 2005 | 43 | 0.080 |
Why?
|
| Enzyme Inhibitors | 2 | 2015 | 396 | 0.080 |
Why?
|
| Animals, Newborn | 2 | 1998 | 323 | 0.080 |
Why?
|
| Superoxides | 2 | 2004 | 51 | 0.080 |
Why?
|
| Membrane Potential, Mitochondrial | 2 | 2018 | 71 | 0.070 |
Why?
|
| Sympatholytics | 1 | 2005 | 13 | 0.070 |
Why?
|
| Pyridinium Compounds | 1 | 2005 | 21 | 0.070 |
Why?
|
| Garlic | 2 | 2015 | 31 | 0.060 |
Why?
|
| Cell Respiration | 1 | 2004 | 33 | 0.060 |
Why?
|
| Electron Transport Complex III | 1 | 2004 | 12 | 0.060 |
Why?
|
| Drug Combinations | 1 | 2004 | 89 | 0.060 |
Why?
|
| Motor Activity | 3 | 2008 | 393 | 0.060 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2003 | 13 | 0.060 |
Why?
|
| Phosphoenolpyruvate | 1 | 2003 | 4 | 0.060 |
Why?
|
| Molecular Structure | 2 | 2016 | 467 | 0.060 |
Why?
|
| Propidium | 1 | 2003 | 18 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 445 | 0.060 |
Why?
|
| Intracellular Membranes | 1 | 2003 | 34 | 0.060 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2023 | 35 | 0.060 |
Why?
|
| Monosaccharides | 1 | 2003 | 9 | 0.060 |
Why?
|
| Antiparkinson Agents | 1 | 2002 | 11 | 0.060 |
Why?
|
| 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 1 | 2002 | 8 | 0.060 |
Why?
|
| Imines | 1 | 2002 | 9 | 0.060 |
Why?
|
| Levodopa | 1 | 2002 | 19 | 0.060 |
Why?
|
| Stereoisomerism | 1 | 2003 | 162 | 0.060 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2002 | 50 | 0.060 |
Why?
|
| Membrane Potentials | 1 | 2003 | 213 | 0.050 |
Why?
|
| Endoplasmic Reticulum | 1 | 2003 | 101 | 0.050 |
Why?
|
| Cell Death | 1 | 2003 | 260 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2000 | 1534 | 0.050 |
Why?
|
| Florida | 1 | 2023 | 358 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2003 | 528 | 0.050 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2001 | 47 | 0.050 |
Why?
|
| Mothers | 1 | 2023 | 164 | 0.050 |
Why?
|
| N-Methylaspartate | 1 | 2001 | 55 | 0.050 |
Why?
|
| Drug Discovery | 1 | 2021 | 77 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2023 | 871 | 0.050 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2001 | 131 | 0.050 |
Why?
|
| Brain Chemistry | 1 | 2000 | 134 | 0.050 |
Why?
|
| Biomimetics | 1 | 2019 | 10 | 0.050 |
Why?
|
| Triazoles | 1 | 2000 | 85 | 0.050 |
Why?
|
| Infant | 1 | 2023 | 1014 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2002 | 550 | 0.040 |
Why?
|
| Serine Endopeptidases | 1 | 2019 | 36 | 0.040 |
Why?
|
| Quinolinic Acid | 1 | 1999 | 1 | 0.040 |
Why?
|
| Clorgyline | 1 | 1998 | 4 | 0.040 |
Why?
|
| Selegiline | 1 | 1998 | 6 | 0.040 |
Why?
|
| Sharks | 1 | 1998 | 3 | 0.040 |
Why?
|
| Enzyme Induction | 1 | 1998 | 48 | 0.040 |
Why?
|
| Inflammation | 1 | 2003 | 577 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2019 | 350 | 0.040 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2019 | 117 | 0.040 |
Why?
|
| Free Radical Scavengers | 1 | 1998 | 65 | 0.040 |
Why?
|
| Dopamine Antagonists | 1 | 1998 | 39 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2000 | 304 | 0.040 |
Why?
|
| Pituitary-Adrenal System | 1 | 1998 | 36 | 0.040 |
Why?
|
| Membrane Transport Proteins | 1 | 1998 | 88 | 0.040 |
Why?
|
| Pregnancy Outcome | 1 | 1998 | 90 | 0.040 |
Why?
|
| Petroselinum | 1 | 2017 | 4 | 0.040 |
Why?
|
| Computer Simulation | 1 | 2019 | 347 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 1998 | 137 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 1998 | 197 | 0.040 |
Why?
|
| Protein Binding | 1 | 2019 | 913 | 0.040 |
Why?
|
| Tubulin | 1 | 2016 | 80 | 0.040 |
Why?
|
| Cyclooxygenase 2 | 1 | 2016 | 92 | 0.040 |
Why?
|
| Breast | 1 | 2017 | 134 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 1998 | 338 | 0.030 |
Why?
|
| Anthracenes | 1 | 2015 | 13 | 0.030 |
Why?
|
| Butadienes | 1 | 2015 | 30 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2015 | 20 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 430 | 0.030 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2015 | 31 | 0.030 |
Why?
|
| Child | 1 | 2023 | 2875 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2015 | 87 | 0.030 |
Why?
|
| Dacarbazine | 1 | 2015 | 6 | 0.030 |
Why?
|
| Etoposide | 1 | 2015 | 21 | 0.030 |
Why?
|
| Nitriles | 1 | 2015 | 66 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 93 | 0.030 |
Why?
|
| Inhibitor of Apoptosis Proteins | 1 | 2015 | 32 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2017 | 420 | 0.030 |
Why?
|
| Anticarcinogenic Agents | 1 | 2015 | 65 | 0.030 |
Why?
|
| Methylation | 1 | 2015 | 102 | 0.030 |
Why?
|
| Cognition | 1 | 1998 | 373 | 0.030 |
Why?
|
| Lysine | 1 | 2015 | 104 | 0.030 |
Why?
|
| Selenium | 1 | 1997 | 144 | 0.030 |
Why?
|
| Pyridines | 1 | 2015 | 113 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2015 | 171 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2015 | 98 | 0.030 |
Why?
|
| Protein Array Analysis | 1 | 2014 | 26 | 0.030 |
Why?
|
| Male | 7 | 2012 | 18870 | 0.030 |
Why?
|
| Adipokines | 1 | 2014 | 24 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2014 | 140 | 0.030 |
Why?
|
| Thymine | 1 | 2013 | 25 | 0.030 |
Why?
|
| Comet Assay | 1 | 2013 | 72 | 0.030 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2013 | 75 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2013 | 126 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2015 | 360 | 0.030 |
Why?
|
| Cytochromes c | 1 | 2012 | 45 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2015 | 878 | 0.030 |
Why?
|
| Heme Oxygenase-1 | 1 | 2012 | 46 | 0.030 |
Why?
|
| Dihydrotestosterone | 1 | 2011 | 26 | 0.030 |
Why?
|
| Caspases | 1 | 2012 | 132 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2013 | 392 | 0.030 |
Why?
|
| Brain | 1 | 1998 | 1268 | 0.020 |
Why?
|
| Mutation | 1 | 2015 | 1023 | 0.020 |
Why?
|
| Pregnancy | 3 | 1998 | 1503 | 0.020 |
Why?
|
| Corticosterone | 2 | 1999 | 73 | 0.020 |
Why?
|
| Oxygen | 1 | 2008 | 193 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2008 | 1530 | 0.010 |
Why?
|
| Catechols | 1 | 2002 | 3 | 0.010 |
Why?
|
| Free Radicals | 1 | 2002 | 72 | 0.010 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2002 | 35 | 0.010 |
Why?
|
| Superoxide Dismutase | 1 | 2002 | 149 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2002 | 485 | 0.010 |
Why?
|
| Tritium | 1 | 2000 | 48 | 0.010 |
Why?
|
| Amphetamine | 1 | 2000 | 15 | 0.010 |
Why?
|
| Stereotyped Behavior | 1 | 2000 | 20 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2000 | 145 | 0.010 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2000 | 75 | 0.010 |
Why?
|
| Naloxone | 1 | 1999 | 50 | 0.010 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1998 | 23 | 0.010 |
Why?
|
| Morphine | 1 | 1999 | 80 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1998 | 103 | 0.010 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 1998 | 45 | 0.010 |
Why?
|
| Maze Learning | 1 | 1998 | 100 | 0.010 |
Why?
|
| Reference Values | 1 | 1998 | 204 | 0.010 |
Why?
|
| Receptors, Dopamine D2 | 1 | 1998 | 68 | 0.010 |
Why?
|
| Homovanillic Acid | 1 | 1997 | 10 | 0.010 |
Why?
|
| Microdialysis | 1 | 1997 | 18 | 0.010 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 1997 | 27 | 0.010 |
Why?
|
| Quinpirole | 1 | 1997 | 16 | 0.010 |
Why?
|
| Memory | 1 | 1998 | 165 | 0.010 |
Why?
|
| Sex Characteristics | 1 | 1998 | 213 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1998 | 287 | 0.010 |
Why?
|